Merck & Co. Inc. (MRK) | Common-Size Statement of Financial Position, Liabilities and Stockholders' Equity
See also
- Johnson & Johnson (JNJ), Common-Size Liabilities and Stockholders' Equity
- Pfizer Inc. (PFE), Common-Size Liabilities and Stockholders' Equity
- Novartis AG (NVS), Common-Size Liabilities and Stockholders' Equity
- GlaxoSmithKline PLC (GSK), Common-Size Liabilities and Stockholders' Equity
- Abbott Laboratories (ABT), Common-Size Liabilities and Stockholders' Equity
- Sanofi (SNY), Common-Size Liabilities and Stockholders' Equity
- Novo Nordisk A/S (NVO), Common-Size Liabilities and Stockholders' Equity
- UnitedHealth Group Inc. (UNH), Common-Size Liabilities and Stockholders' Equity
- Bristol-Myers Squibb Co. (BMY), Common-Size Liabilities and Stockholders' Equity
- AstraZeneca PLC (AZN), Common-Size Liabilities and Stockholders' Equity
- Eli Lilly & Co. (LLY), Common-Size Liabilities and Stockholders' Equity
- Medtronic Inc. (MDT), Common-Size Liabilities and Stockholders' Equity
- Baxter International Inc. (BAX), Common-Size Liabilities and Stockholders' Equity
ˇ Show More
You have visited 10 password protected pages for free. Others contain data covered by 
.
Sign Up Now to get full access to whole website and cut out all advertisements.
Merck & Co. Inc., Common-Size Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity
| Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | Dec 31, 2007 | ||
|---|---|---|---|---|---|---|
 |
Loans payable and current portion of long-term debt | |
|
|
|
|
|
Trade accounts payable | |
|
|
|
|
|
Accrued and other current liabilities | |
|
|
|
|
|
Income taxes payable | |
|
|
|
|
|
Dividends payable | |
|
|
|
|
|
6% Mandatory convertible preferred stock, $1 par value | |
|
|
|
|
|
Current liabilities | % |
% |
% |
% |
% |
|
Long-term debt, excluding current portion | |
|
|
|
|
|
Deferred income taxes and noncurrent liabilities | |
|
|
|
|
|
Noncurrent liabilities | % |
% |
% |
% |
% |
|
Total liabilities | % |
% |
% |
% |
% |
|
Common stock, $0.50 par value | |
|
|
|
|
|
Other paid-in capital | |
|
|
|
|
|
Retained earnings | |
|
|
|
|
|
Accumulated other comprehensive loss | |
|
|
|
|
|
Treasury stock, at cost | |
|
|
|
|
|
Merck & Co., Inc. stockholders’ equity | % |
% |
% |
% |
% |
|
Noncontrolling interests | |
|
|
|
|
|
Total equity | % |
% |
% |
% |
% |
|
Total liabilities and equity | % |
% |
% |
% |
% |
Stock Analysis on Net (www.stock-analysis-on.net)
Copyright © 2012 EBIT Financial Analyses Center